Dr. Jyoti Patel on Delaying Whole Brain Radiation for Brain Metastases

Alectinib was approved for the treatment of patients with ALK-positive non-small cell lung cancer after surgical resection.

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Over the last 5 years, 57% of drugs approved by the FDA for a cancer-related indication did not show a clinical benefit in confirmatory studies.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Compared with docetaxel, adagrasib improved progression-free survival and objective response rate in patients with pretreated KRAS G12C–mutant non–small cell lung cancer.

Tumor-treating fields significantly improved the time to intracranial progression in patients from the phase 3 METIS trial with brain metastases from non-small cell lung cancer.